Acetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity and neurotransmitter levels in the mesolimbic pathway

Behavioural Brain Research

Volumn 226, Issue 1, 2012, Pages 224-234

  Dobbs, Lauren K ^a   Mark, Gregory P ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Dopamine; In vivo microdialysis; Locomotor activity; Methamphetamine

Indexed keywords

ACETYLCHOLINE; DOPAMINE; METHAMPHETAMINE; NEUROTRANSMITTER; OXOTREMORINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LATERODORSAL TEGMENTAL NUCLEI; LIMBIC SYSTEM; LOCOMOTION; MALE; MASS SPECTROMETRY; MICRODIALYSIS; MOUSE; NONHUMAN; PEDUNCULOPONTINE TEGMENTAL NUCLEI; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ACETYLCHOLINE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; MALE; METHAMPHETAMINE; MICE; MOTOR ACTIVITY; MUSCARINIC AGONISTS; NEURAL PATHWAYS; NUCLEUS ACCUMBENS; OXOTREMORINE; SYNAPTIC TRANSMISSION; TEGMENTUM MESENCEPHALI; VENTRAL TEGMENTAL AREA;

EID: 80053598409     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.09.022     Document Type: Article

References (53)

1. Winn P. How best to consider the structure and function of the pedunculopontine tegmental nucleus: evidence from animal studies. J Neurol Sci 2006, 248:234-250.
2. Wang H.L., Morales M. Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. Eur J Neurosci 2009, 29:340-358.
3. Oakman S.A., Faris P.L., Kerr P.E., Cozzari C., Hartman B.K. Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J Neurosci 1995, 15:5859-5869.
4. Omelchenko N., Sesack S.R. Cholinergic axons in the rat ventral tegmental area synapse preferentially onto mesoaccumbens dopamine neurons. J Comp Neurol 2006, 494:863-875.
5. Forster G.L., Blaha C.D. Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area. Eur J Neurosci 2000, 12:3596-3604.
6. Forster G.L., Yeomans J.S., Takeuchi J., Blaha C.D. M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice. J Neurosci 2002, 22:RC190.
7. Lodge D.J., Grace A.A. The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons. Proc Natl Acad Sci U S A 2006, 103:5167-5172.
8. Mena-Segovia J., Winn P., Bolam J.P. Cholinergic modulation of midbrain dopaminergic systems. Brain Res Rev 2008, 58:265-271.
9. Yeomans J.S., Mathur A., Tampakeras M. Rewarding brain stimulation: role of tegmental cholinergic neurons that activate dopamine neurons. Behav Neurosci 1993, 107:1077-1087.
10. Laviolette S.R., Priebe R.P., Yeomans J.S. Role of the laterodorsal tegmental nucleus in scopolamine- and amphetamine-induced locomotion and stereotypy. Pharmacol Biochem Behav 2000, 65:163-174.
11. Westerink B.H. Kwint HF, deVries JB. The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J Neurosci 1996, 16:2605-2611.
12. Westerink B.H., Enrico P., Feimann J., De Vries J.B. The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain. J Pharmacol Exp Ther 1998, 285:143-154.
13. Miller A.D., Blaha C.D. Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat. Eur J Neurosci 2005, 21:1837-1846.
14. Gerber D.J., Sotnikova T.D., Gainetdinov R.R., Huang S.Y., Caron M.G., Tonegawa S., Hyperactivity elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci U S A 2001, 98:15312-15317.
15. Hess G.P., Ulrich H., Breitinger H.G., Niu L., Gameiro A.M., Grewer C., et al. Mechanism-based discovery of ligands that counteract inhibition of the nicotinic acetylcholine receptor by cocaine and MK-801. Proc Natl Acad Sci U S A 2000, 97:13895-13900.
16. Zhang Y., Loonam T.M., Noailles P.A., Angulo J.A. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann N Y Acad Sci 2001, 937:93-120.
17. Shoblock J.R., Sullivan E.B., Maisonneuve I.M., Glick S.D. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology 2003, 165:359-369.
18. Dobbs L.K., Mark G.P. Comparison of systemic and local methamphetamine treatment on acetylcholine and dopamine levels in the ventral tegmental area in the mouse. Neuroscience 2008, 156:700-711.
19. Zombeck J.A., Gupta T., Rhodes J.S. Evaluation of a pharmacokinetic hypothesis for reduced locomotor stimulation from methamphetamine and cocaine in adolescent versus adult male C57BL/6J mice. Psychopharmacology (Berl) 2009, 201:589-599.
20. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol Rev 1987, 94:469-492.
21. Jones C.D., Bartee J.A., Leite-Browning M.L., Blackshear M.A. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?. Cell Mol Biol (Noisy-le-Grand, France) 2007, 53:15-22.
22. Itzhak Y., Martin J.L., Ali S.F. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:1177-1183.
23. National Research Council of the National Academies Guidelines for the care and use of mammals in neuroscience and behavioral research 2003, The National Academies Press, Washington, DC.
24. Potter L.T., Ballesteros L.A., Bichajian L.H., Ferrendelli C.A., Fisher A., Hanchett H.E., et al. Evidence of paired M2 muscarinic receptors. Mol Pharmacol 1991, 39:211-221.
25. Vanderheyden P., Gies J.P., Ebinger G., De Keyser J., Landry Y., Vauquelin G. Human M1-, M2- and M3-muscarinic cholinergic receptors: binding characteristics of agonists and antagonists. J Neurol Sci 1990, 97:67-80.
26. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego, CA. 2nd ed.
27. Mark G.P., Kinney A.E., Grubb M.C., Zhu X., Finn D.A., Mader S., et al. Injection of oxotremorine in the nucleus accumbens shell reduces cocaine but not food self-administration. Brain Res 2006, 1123:51-59.
28. Gililland-Kaufman K.R., Tanchuck M.A., Ford M.M., Crabbe J.C., Beadles-Bohling A.S., Snelling C., et al. The neurosteroid environment in the hippocampus exerts bi-directional effects on seizure susceptibility in mice. Brain Res 2008, 1243:113-123.
29. You Z.B., Wang B., Zitzman D., Wise R.A. Acetylcholine release in the mesocorticolimbic dopamine system during cocaine seeking: conditioned and unconditioned contributions to reward and motivation. J Neurosci 2008, 28:9021-9029.
30. Kodama T., Honda Y. Acetylcholine releases of mesopontine PGO-on cells in the lateral geniculate nucleus in sleep-waking cycle and serotonergic regulation. Prog Neuropsychopharmacol Biol Psychiatry 1996, 20:1213-1227.
31. Koyama Y., Sakai K. Modulation of presumed cholinergic mesopontine tegmental neurons by acetylcholine and monoamines applied iontophoretically in unanesthetized cats. Neuroscience 2000, 96:723-733.
32. Wilcox K.S., Grant S.J., Burkhart B.A., Christoph G.R. In vitro electrophysiology of neurons in the lateral dorsal tegmental nucleus. Brain Res Bull 1989, 22:557-560.
33. Luebke J.I., McCarley R.W., Greene R.W. Inhibitory action of muscarinic agonists on neurons in the rat laterodorsal tegmental nucleus in vitro. J Neurophysiol 1993, 70:2128-2135.
34. Chapman C.A., Yeomans J.S., Blaha C.D., Blackburn J.R. Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus. Neuroscience 1997, 76:177-186.
35. Floresco S.B., West A.R., Ash B., Moore H., Grace A.A. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 2003, 6:968-973.
36. Sulzer D., Sonders M.S., Poulsen N.W., Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 2005, 75:406-433.
37. Lacey M.G., Calabresi P., North R.A. Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors. J Pharmacol Exp Ther 1990, 253:395-400.
38. Mereu G., Yoon K.W., Boi V., Gessa G.L., Naes L., Westfall T.C. Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol 1987, 141:395-399.
39. De Boer P., Abercrombie E.D. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes. J Pharmacol Exp Ther 1996, 277:775-783.
40. Ikemoto S., Wise R.A. Rewarding effects of the cholinergic agents carbachol and neostigmine in the posterior ventral tegmental area. J Neurosci 2002, 22:9895-9904.
41. Maskos U. The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology. Br J Pharmacol 2008, 153(Suppl 1):S438-S445.
42. Winn P. Experimental studies of pedunculopontine functions: are they motor, sensory or integrative?. Parkinsonism Relat Disord 2008, 14(Suppl 2):S194-S198.
43. Li M., Yasuda R.P., Wall S.J., Wellstein A., Wolfe B.B. Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors. Mol Pharmacol 1991, 40:28-35.
44. Vilaro M.T., Wiederhold K-H., Palacios J.M., Mengod G. Muscarinic cholinergic receptors in the rat caudate-putamen and olfactory tubercle belong predominantly to the m4 class: in situ hybridization and receptor autoradiography evidence. Neuroscience 1991, 40:159-167.
45. Vilaro M.T., Wiederhold K.H., Palacios J.M., Mengod G. Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography. Neuroscience 1992, 47:367-393.
46. Buckley N.J., Bonner T.I., Brann M.R. Localization of a family of muscarinic receptor mRNAs in rat brain. J Neurosci 1988, 8:4646-4652.
47. Schilstrom B., Nomikos G.G., Nisell M., Hertel P., Svensson T.H. N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience 1998, 82:781-789.
48. Blaha C.D., Yang C.R., Floresco S.B., Barr A.M., Phillips A.G. Stimulation of the ventral subiculum of the hippocampus evokes glutamate receptor-mediated changes in dopamine efflux in the rat nucleus accumbens. Eur J Neurosci 1997, 9:902-911.
49. Fields H.L., Hjelmstad G.O., Margolis E.B., Nicola S.M. Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement. Annu Rev Neurosci 2007, 30:289-316.
50. Kalivas P.W., Duffy P. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat. Bio Psychiat 1989, 25:913-928.
51. Swanson C.J., Kalivas P.W. Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area. J Pharmacol Exp Ther 2000, 292:406-414.
52. Alderson H.L., Latimer M.P., Winn P. Involvement of the laterodorsal tegmental nucleus in the locomotor response to repeated nicotine administration. Neurosci Lett 2005, 380:335-339.
53. Nelson C.L., Wetter J.B., Milovanovic M., Wolf M.E. The laterodorsal tegmentum contributes to behavioral sensitization to amphetamine. Neuroscience 2007, 146:41-49.